SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-19-047186
Filing Date
2019-08-23
Accepted
2019-08-23 20:14:02
Documents
1
Period of Report
2019-08-20

Document Format Files

Seq Description Document Type Size
1 4/A a4a.html 4/A  
1 4/A a4a.xml 4/A 9302
  Complete submission text file 0001104659-19-047186.txt   10726
Mailing Address 565 EVERETT AVENUE PALO ALTO CA 94301
Business Address
AKKARAJU SRINIVAS (Reporting) CIK: 0001253170 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35668 | Film No.: 191050393

Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations